Merck KGaA (OTCMKTS:MKGAF) Short Interest Update

Key Points

• Short interest in Merck KGaA increased by 25.3% in August, with a total of 483,800 shares shorted as of August 31st.
• The company's current days-to-cover ratio is 604.8 days, indicating a potential challenge for short sellers based on the average daily trading volume.
• Merck KGaA's stock is currently priced at $130.55, with a market capitalization of $16.87 billion and a PE ratio of 19.93.

Merck KGaA (OTCMKTS:MKGAF - Get Free Report) was the target of a large increase in short interest during the month of August. As of August 31st, there was short interest totaling 483,800 shares, an increase of 25.3% from the August 15th total of 386,000 shares. Currently, 0.4% of the shares of the stock are sold short. Based on an average trading volume of 800 shares, the short-interest ratio is currently 604.8 days. Based on an average trading volume of 800 shares, the short-interest ratio is currently 604.8 days. Currently, 0.4% of the shares of the stock are sold short.

Merck KGaA Trading Up 0.6%

Shares of OTCMKTS MKGAF traded up $0.82 during midday trading on Friday, reaching $127.40. 530 shares of the stock were exchanged, compared to its average volume of 982. The company has a market capitalization of $16.47 billion, a price-to-earnings ratio of 19.45 and a beta of 0.96. The business has a 50-day simple moving average of $129.02 and a two-hundred day simple moving average of $133.02. The company has a debt-to-equity ratio of 0.27, a current ratio of 1.31 and a quick ratio of 0.84. Merck KGaA has a 12 month low of $118.05 and a 12 month high of $183.17.

About Merck KGaA

Merck KGaA operates as a science and technology company in Germany. It operates through Life Science, Healthcare, and Electronics segments. The company's Life Science segment offers tools, chemicals, and equipment for academic labs, biotech, and pharmaceutical manufacturers, as well as industrial sector.